companydata.dkAMPLEXA GENETICS A/S: Financial statements 2016
CVR: 29428441
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 439,860 and a net result of DKK -2,695,686 compared with DKK -3,373,569 the year before. That is an increase of 179.3% compared with the year before. Equity amounted to DKK -22,278,092.
- Gross Profit
- 439,860 kr.
- Profit/Loss
- -2,695,686 kr.
- Equity
- -22,278,092 kr.
- Total Assets
- 2,704,566 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 440 t. | -2.7 mio. | -22.3 mio. | - |
| 2015 | - | 157 t. | -3.4 mio. | -19.6 mio. | - |
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
How creditworthy is AMPLEXA GENETICS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
AMPLEXA GENETICS A/S has published its annual report for 2015. Gross profit came to DKK 157,496, and the net result was DKK -3,373,569.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.